Comprehensive Molecular Analysis of Mismatch Repair Gene Defects in Suspected Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Cases

被引:32
|
作者
Mueller, James [1 ,2 ,3 ]
Gazzoli, Isabella [1 ,2 ,3 ]
Bandipalliam, Prathap [4 ,5 ]
Garber, Judy E. [4 ,5 ]
Syngal, Sapna [4 ,5 ]
Kolodner, Richard D. [1 ,2 ,3 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA
[4] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA
关键词
REVISED BETHESDA GUIDELINES; MICROSATELLITE INSTABILITY; INSTITUTE WORKSHOP; ENDOMETRIAL CANCER; GERMLINE MUTATIONS; GENOMIC DELETIONS; CLINICAL-CRITERIA; MSH6; MUTATIONS; MLH1; PMS2;
D O I
10.1158/0008-5472.CAN-09-0358
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An accurate algorithm is essential for effective molecular diagnosis of hereditary colorectal cancer (CRC). Here, we have extended the analysis of 71 CRC cases suspected to be Lynch syndrome cases for MSH2, MLH1, MSH6, and PMS2 gene defects. All cases were screened for mutations in MSH2,MLH1, and MSH6, and all cases where tumors were available were screened for microsatellite instability (MSI) and expression of MSH2 and MLH1. Subsequently, mutation-negative cases were screened for MLH1 methylation and mutations in PMS2. Of the MSI-high (MSI-H) cases, 96% had a mismatch repair (MMR) gene defect, mostly involving MSH2 or MLH1; one PMS2 mutation, one MLH1 epimutation, and no MSH6 mutations were found. Four of the 28 MSI-H cases, including one Amsterdam criteria case, had biallelic tumor MLH1 methylation, indicating that sporadic cases can be admixed in with Lynch syndrome cases, even those meeting the strongest criteria for Lynch syndrome. MMR gene defects were found in similar frequency in cases where tumors were and were not available. One MLH1 and one MSH2 deletion mutation were found in MSI-stable/low cases, indicating that MSI testing can exclude cases with pathogenic mutations. Our analysis supports a diagnostic algorithm where cases are selected for analysis based on clinical criteria or prediction models; isolated sporadic young-onset cases can be prescreened by tumor testing, whereas familial cases may be directly subjected to molecular analysis for mutations in MMR genes followed by MSI, protein expression, and DNA methylation analysis to aid in the resolution of mutation-negative cases. [Cancer Res 2009;69(17):7053-61]
引用
收藏
页码:7053 / 7061
页数:9
相关论文
共 50 条
  • [1] New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing
    Gruber, SB
    GASTROENTEROLOGY, 2006, 130 (02) : 577 - 587
  • [2] Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer
    Stormorken, AT
    Bowitz-Lothe, IM
    Norèn, T
    Kure, E
    Aase, S
    Wijnen, J
    Apold, J
    Heimdal, K
    Moller, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4705 - 4712
  • [3] DNA-mismatch repair and hereditary nonpolyposis colorectal cancer syndrome
    Müller, A
    Korabiowska, M
    Brinck, U
    IN VIVO, 2003, 17 (01): : 55 - 59
  • [4] Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome
    Uffe Birk Jensen
    Lone Sunde
    Susanne Timshel
    Britta Halvarsson
    Anja Nissen
    Inge Bernstein
    Mef Nilbert
    Breast Cancer Research and Treatment, 2010, 120 : 777 - 782
  • [5] Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome
    Jensen, Uffe Birk
    Sunde, Lone
    Timshel, Susanne
    Halvarsson, Britta
    Nissen, Anja
    Bernstein, Inge
    Nilbert, Mef
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (03) : 777 - 782
  • [6] Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics
    Robinson, Kristina Lagerstedt
    Liu, Tao
    Vandrovcova, Jana
    Halvarsson, Britta
    Clendenning, Mark
    Frebourg, Thierry
    Papadopoulos, Nickolas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Peltomaki, Paivi
    Kolodner, Richard D.
    Nilbert, Mef
    Lindblom, Annika
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (04) : 291 - 299
  • [7] DNA mismatch repair and hereditary nonpolyposis colorectal cancer
    Scott, RJ
    ONKOLOGIE, 1997, 20 (01): : 42 - 47
  • [8] Hereditary Nonpolyposis Colorectal Cancer (HNPCC)/Lynch Syndrome
    Steinke, Verena
    Engel, Christoph
    Buettner, Reinhard
    Schackert, Hans Konrad
    Schmiegel, Wolff H.
    Propping, Peter
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2013, 110 (03): : 32 - U28
  • [9] LYNCH SYNDROME (HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER)
    MOYASANZ, A
    GARCIAPASTOR, P
    SENABRE, JJG
    GIMENEZ, FD
    RODERO, DR
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1994, 86 (05) : 831 - 834
  • [10] Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer).
    Hampel, H
    Frankel, WL
    Martin, E
    Arnold, M
    Khanduja, K
    Kuebler, P
    Nakagawa, H
    Sotamaa, K
    Prior, TW
    Westman, J
    Panescu, J
    Fix, D
    Lockman, J
    Comeras, I
    de la Chapelle, A
    Ellison, C
    Melvin, S
    Winston, J
    Adeli, A
    Burak, W
    Chadwick, R
    Elkhatib, I
    Hemingway, T
    Jamieson, K
    Johnson, C
    LaJeunesse, J
    Liyanarachchi, S
    Rangel, P
    Soble, D
    Walker, M
    Wise, T
    Zhang, Y
    Schlanger, R
    Aguilar, P
    Hura, D
    Keith, J
    Kerner, B
    Lavalle, G
    Taylor, C
    Vara, T
    Zangmeister, J
    DeVictor, S
    Hines, L
    Lindsey, M
    Madhavan, J
    Padmanabhan, A
    Hamelberg, K
    Niemann, T
    Behrens, BC
    Blair, SC
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (18): : 1851 - 1860